ISMPP Highlights
Transparency Matters – Take the Transparency Pledge!
Transparency Matters is a call to action launched by Medical Publishing Insights & Practices (MPIP), designed to raise awareness, provide resources, and improve the quality and transparency in reporting the results of industry-sponsored research. Similar to ISMPP, Transparency Matters seeks to…
ISMPP Members Offered Discount on EMWA Membership
The European Medical Writers Association (EMWA) is offering ISMPP members a 10% discount on EMWA membership. EMWA represents, supports, and trains medical communication professionals. It has more than 1,000 members in Europe and beyond. Members work in all sectors of medical writing…
Record-Setting Attendance at 2017 European Meeting of ISMPP
With 254 attendees participating in the European Meeting of ISMPP, January 17-18, 2017, in London, UK, the Society achieved a record-setting attendance for this increasingly popular conference. Building on its theme, The Evolving Role of Publication Professionals in a Multi-Stakeholder Environment, the meeting focused on…
Message from Our Leadership
Robert J. Matheis
ISMPP President and CEO
News and Trends
RWE: A Brave New World for the Medical Publications Professional
Real-World Evidence (RWE), according to the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), comprises “Data used for decision-making that are not collected in conventional randomized controlled trials (RCTs).” RWE is not new; collection of RWE has been mandated for the pharmaceutical industry for many years…
Meta-analysis and Mixed Treatment Comparison Analysis – Powerful Tools with Benefits and Challenges
Evidence-based healthcare decision making is gaining global acceptance in both healthcare policy and clinical practice. Randomized controlled trials (RCTs) are the “gold standard” of evidence, but these studies are usually limited to comparison of two treatments, and thus cannot represent the entirety of treatment options or patient populations…
HEOR: Why It Is Changing the World of Medical Publications
Health economics and outcomes research (HEOR) has been the fastest-growing function in the pharmaceutical industry for a decade or more. Medical publication professionals are seeing publication plans increasingly populated by HEOR studies – particularly post-launch. While medical publication professionals are accustomed to working with…
What Would You Do?
In our role as medical publication professionals, we may occasionally encounter situations in which it is not obvious how to ensure good publication practice. Have you ever wished you could consult the ISMPP membership for guidance when these situations arise? Here’s your opportunity!
What Would You Do? is a section of The MAP that presents case scenarios as an educational tool for medical publication professionals. The section provides a case scenario to ponder, and readers are invited to participate in a poll by selecting one of the listed solutions. Readers can also submit their thoughts on the scenario anonymously. The poll results, plus educational insights, are posted in a later issue for readers to digest.
POLL RESULTS: Delayed Review Calls Authorship into Question
You are a company medical publication professional. The lead author of a manuscript in development was key in acquiring data for the study and actively engaged in the initial discussions that shaped the outline for the paper. However, he/she was slow to send feedback…
ISMPP (pronounced IzMap) is the only nonprofit organization founded by medical publication professionals for medical publication professionals